[1] ZHANG J Q, PIÑEYRO P, CHEN Q, et al. Full-length genome sequences of senecavirus a from recent idiopathic vesicular disease outbreaks in U. S. swine[J]. Genome Announc, 2015, 3(6):e01270-15.
[2] HALES L M, KNOWLES N J, REDDY P S, et al. Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus[J]. J Gen Virol, 2008, 89(5):1265-1275.
[3] CHEN Z H, YUAN F F, LI Y H, et al. Construction and characterization of a full-length cDNA infectious clone of emerging porcine Senecavirus A[J]. Virology, 2016, 497:111-124.
[4] FALLAUX F J, BOUT A, VAN DER VELDE I, et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses[J]. Hum Gene Ther, 1998, 9(13):1909-1917.
[5] REDDY P S, BURROUGHS K D, HALES L M, et al. Seneca valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers[J]. JNCI, 2007, 99(21):1623-1633.
[6] SINGH K, CORNER S, CLARK S G, et al. Seneca valley virus and vesicular lesions in a pig with idiopathic vesicular disease[J]. J Vet Sci Technol, 2012, 3(6):123.
[7] PASMA T, DAVIDSON S, SHAW S L. Idiopathic vesicular disease in swine in Manitoba[J]. Can Vet J, 2008, 49(1):84-85.
[8] VANNUCCI F A, LINHARES D C L, BARCELLOS D E S N, et al. Identification and complete genome of seneca valley virus in vesicular fluid and sera of pigs affected with idiopathic vesicular disease, Brazil[J]. Transbound Emerg Dis, 2015, 62(6):589-593.
[9] LEME R A, ZOTTI E, ALCÂNTARA B K, et al. Senecavirus A:an emerging vesicular infection in brazilian pig herds[J]. Transbound Emerg Dis, 2015, 62(6):603-611.
[10] LEME R A, OLIVEIRA T E, ALCANTARA B K, et al. Clinical manifestations of senecavirus a infection in neonatal pigs, Brazil, 2015[J]. Emerg Infect Dis, 2016, 22(7):1238-1241.
[11] LEME R A, ALFIERI A F, ALFIERI A A. Update on senecavirus infection in pigs[J]. Viruses, 2017, 9(7):170.
[12] WU Q, ZHAO X, BAI Y, et al. The first identification and complete genome of Senecavirus A affecting pig with idiopathic vesicular disease in China[J]. Transbound Emerg Dis, 2017, 64(5):1633-1640.
[13] ZHANG X, XIAO J, BA L, et al. Identification and genomic characterization of the emerging Senecavirus A in southeast China, 2017[J]. Transbound Emerg Dis, 2018, 65(2):297-302.
[14] ZHU Z, YANG F, CHEN P, et al. Emergence of novel Seneca Valley virus strains in China, 2017[J]. Transbound Emerg Dis, 2017, 64(4):1024-1029.
[15] JOSHI L R, FERNANDES M H, CLEMENT T, et al. Pathogenesis of Senecavirus A infection in finishing pigs[J]. J Gen Virol, 2016, 97(12):3267-3279.
[16] SAENG-CHUTO K, RODTIAN P, TEMEEYASEN G, et al. The first detection of Senecavirus A in pigs in Thailand, 2016[J]. Transbound Emerg Dis, 2018, 65(1):285-288.
[17] SUN D, VANNUCCI F, KNUTSON T P, et al. Emergence and whole-genome sequence of Senecavirus A in Colombia[J]. Transbound Emerg Dis, 2017, 64(5):1346-1349.
[18] WANG H W, LI C, ZHAO B, et al. Complete genome sequence and phylogenetic analysis of Senecavirus A isolated in Northeast China in 2016[J]. Arch Virol, 2017, 162(10):3173-3176.
[19] LIU J, REN X, LI Z, et al. Genetic and phylogenetic analysis of reemerged novel Seneca Valley virus strains in Guangdong province, 2017[J]. Transbound Emerg Dis, 2018, 65(3):614-617.
[20] ARENDS M J, MORRIS R G, WYLLIE A H. Apoptosis. The role of the endonuclease[J]. Am J Pathol, 1990, 136(3):593-608.
[21] DANTHI P. Viruses and the diversity of cell death[J]. Annu Rev Virol, 2016, 3:533-553.
[22] TEODORO J G, BRANTON P E. Regulation of apoptosis by viral gene products[J]. J Virol, 1997, 71(3):1739-1746.
[23] HUBER H J, DUESSMANN H, WENUS J, et al. Mathematical modelling of the mitochondrial apoptosis pathway[J]. Biochim Biophys Acta, 2011, 1813(4):608-615.
[24] ICHIM G, TAIT S W G. A fate worse than death:apoptosis as an oncogenic process[J]. Nat Rev Cancer, 2016, 16(8):539-548.
[25] GALLUZZI L, BRENNER C, MORSELLI E, et al. Viral control of mitochondrial apoptosis[J]. PLoS Pathog, 2008, 4(5):e1000018.
[26] ELMORE S. Apoptosis:a review of programmed cell death[J]. Toxicol Pathol, 2007, 35(4):495-516.
[27] ZHOU X C, JIANG W B, LIU Z S, et al. Virus infection and death receptor-mediated apoptosis[J]. Viruses, 2017, 9(11):316.
[28] EVERETT H, MCFADDEN G. Apoptosis:an innate immune response to virus infection[J]. Trends Microbiol, 1999, 7(4):160-165.
[29] MILES L A, BURGA L N, GARDNER E E, et al. Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus[J]. J Clin Invest, 2017, 127(8):2957-2967.
[30] QIAN S H, FAN W C, LIU T T, et al. Seneca valley virus suppresses host type I interferon production by targeting adaptor proteins MAVS, TRIF, and TANK for cleavage[J]. J Virol, 2017, 91(16):e00823-17.
[31] XUE Q, LIU H S, ZHU Z X, et al. Seneca valley virus 3Cpro abrogates the IRF3-and IRF7-mediated innate immune response by degrading IRF3 and IRF7[J]. Virology, 2018, 518:1-7.
[32] XUE Q, LIU H S, ZHU Z X, et al. Seneca valley virus 3C protease negatively regulates the type I interferon pathway by acting as a viral deubiquitinase[J]. Antiviral Res, 2018, 160:183-189.
[33] LI P F, ZHANG X L, CAO W J, et al. RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication[J]. Virol J, 2018, 15(1):162.
[34] STOTT E J, KILLINGTON R A. Rhinoviruses[J]. Annu Rev Microbiol, 1972, 26:503-524.
[35] LEWIS-ROGERS N, CRANDALL K A. Evolution of picornaviridae:an examination of phylogenetic relationships and cophylogeny[J]. Mol Phylogenet Evol, 2010, 54(3):995-1005.
[36] RACANIELLO R. Picornaviridae:the viruses and their replication[M]//Fields Virology. KNIPE D M, HOWLEY P M. 4th ed. Philadelphia:Lippincott Raven press, 2013.
[37] PALMENBERG A C, GERN J E. Classification and evolution of human rhinoviruses[J]. Methods Mol Biol, 2015, 1221:1-10.
[38] PALMENBERG A C, SPIRO D, KUZMICKAS R, et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution[J]. Science, 2009, 324(5923):55-59.
[39] HULL H F, WARD N A, HULL B P, et al. Paralytic poliomyelitis:Seasoned strategies, disappearing disease[J]. Lancet, 1994, 343(8909):1331-1337.
[40] CROFT S N, WALKER E J, GHILDYAL R. Picornaviruses and apoptosis:subversion of cell death[J]. MBIO, 2017, 8(5):E01009-17.
[41] BELOV G A, ROMANOVA L I, TOLSKAYA E A, et al. The major apoptotic pathway activated and suppressed by poliovirus[J]. J Virol, 2003, 77(1):45-56.
[42] IRURZUN A, ARROYO J, ALVAREZ A, et al. Enhanced intracellular calcium concentration during poliovirus infection[J]. J Virol, 1995, 69(8):5142-5146.
[43] BRISAC C, TÉOULÉ F, AUTRET A, et al. Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis[J]. J Virol, 2010, 84(23):12226-12235.
[44] WANG J C, WANG Y Q, LIU J, et al. A critical role of n-myc and stat interactor (nmi) in foot-and-mouth disease virus (FMDV) 2C-induced apoptosis[J]. Virus Res, 2012, 170(1-2):59-65.
[45] PENG J M, LIANG S M, LIANG C M. VP1 of foot-and-mouth disease virus induces apoptosis via the akt signaling pathway[J]. J Biol Chem, 2004, 279(50):52168-52174. |